Revision within 5 years

By type of shoulder arthroplasty
Reverse total shoulder arthroplasty by demographics
Total anatomical shoulder arthroplasty by demographics

Shoulder » Survival » Revision within 5 years » By type of shoulder arthroplasty

FIGURE Cumulative revision percentage of primary shoulder arthroplasties by type of shoulder arthroplasty in the Netherlands in 2014-2019 (n=16,309)

TABLE Cumulative 5-years revision percentage

Type of primary shoulder arthroplasty		Cumulative 5-year revision percentage
Type of primary shoulder arthroplasty	Number (n)	Competing Risk¹ (95% CI)	Kaplan Meier (95% CI)
Reverse	10,782	4.4 (3.9-4.9)	4.7 (4.1-5.2)
Total anatomical	3,587	5.8 (4.8-7.0)	5.9 (4.8-7.1)
Hemi	1,940	11.3 (9.6-13.1)	11.9 (10.0-13.7)

¹ The cumulative revision percentage using the competing risk method is shown in the figure.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
Reverse: reverse total shoulder arthroplasty; Total anatomical: total anatomical shoulder arthroplasty; Hemi: shoulder hemiarthroplasty. CI: confidence interval

Shoulder » Survival » Revision within 5 years » Reverse total shoulder arthroplasty by demographics

TABLE Cumulative 5-year revision percentages of primary reverse total shoulder arthroplasties by demographics in the Netherlands in 2014-2019

		Cumulative 5-year revision percentage
	Number (n)	Competing Risk (95% CI)	Kaplan Meier (95% CI)
Total	10,782	4.4 (3.9-4.9)	4.7 (4.1-5.2)
Gender
Men	2,478	8.9 (7.5-10.4)	9.4 (7.8-10.9)
Women	8,293	3.1 (2.6-3.7)	3.3 (2.8-3.9)
Age (years)
<50	83	n.a.	n.a.
50-59	365	n.a.	n.a.
60-69	2,300	7.0 (5.7-8.6)	7.3 (5.8-8.7)
70-79	5,454	4.0 (4.4-4.8)	4.3 (3.5-5.0)
≥80	2,568	2.2 (1.7-2.9)	2.4 (1.7-3.0)
Diagnosis
Osteoarthritis	3,276	3.9 (3.1-4.9)	4.2 (3.2-5.1)
Other	7,477	4.8 (4.1-5.6)	4.9 (4.2-5.6)
ASA score
I	583	8.5 (5.4-13.4)	8.8 (4.9-12.6)
II	6,334	3.7 (3.2-4.4)	3.9 (3.3-4.5)
III-IV	3,707	4.8 (3.9-5.8)	5.2 (4.2-6.2)
Walch score
A1	4,970	4.5 (3.8-5.3)	4.7 (3.9-5.5)
A2	2,289	4.5 (3.5-5.9)	4.8 (3.5-6.0)
B1	993	3.4 (2.3-5.0)	3.4 (2.1-4.7)
B2	555	n.a.	n.a.
B3	183	n.a.	n.a.
C
Body Mass Index (kg/m²)
Underweight (≤18,5)	109	n.a.	n.a.
Normal weight (>18,5-25)	3,017	4.0 (3.1-5.2)	4.3 (3.2-5.5)
Overweight (>25-30)	4,192	4.2 (3.5-5.1)	4.5 (3.7-5.3)
Obesity (>30-40)	3,008	4.8 (3.9-5.8)	4.9 (3.9-5.9)
Morbid obesity (>40)	292	n.a.	n.a.
Smoking
No	9,467	4.3 (3.8-4.9)	4.5 (3.9-5.1)
Yes	404	5.6 (4.2-7.4)	5.8 (4.2-7.3)

Please note: n.a. if <50 cases were at risk; CI: confidence interval.

Shoulder » Survival » Revision within 5 years » Total anatomical shoulder arthroplasty by demographics

TABLE Cumulative 5-year revision percentages of primary total anatomical shoulder arthroplasties by demographics in the Netherlands in 2014-2019

		Cumulative 5-year revision percentage
	Number (n)	Competing Risk (95% CI)	Kaplan Meier (95% CI)
Total	3,587	5.8 (4.8-7.0)	5.9 (4.8-7.1)
Gender
Men	1,065	5.9 (4.3-8.0)	5.9 (4.1-7.8)
Women	2,518	5.8 (4.6-7.3)	5.9 (4.5-7.3)
Age (years)
<50	204	n.a.	n.a.
50-59	622	9.5 (6.5-13.9)	9.7 (6.0-13.3)
60-69	1,383	5.7 (4.4-7.5)	5.8 (4.2-7.4)
70-79	1,093	4.1 (2.6-6.6)	4.2 (2.2-6.3)
≥80	282	n.a.	n.a.
Diagnosis
Osteoarthritis	2,971	5.2 (4.2-6.6)	5.3 (4.1-6.6)
Other	602	9.8 (7.0-13.8)	8.9 (6.0-11.7)
ASA score
I	512	8.1 (5.2-12.8)	7.9 (4.4-11.4)
II	2,365	5.9 (4.7-7.4)	6.0 (4.6-7.4)
III-IV	667	4.0 (2.5-6.4)	3.9 (2.0-5.8)
Walch score
A1	1,453	6.6 (5.0-8.5)	6.7 (4.9-8.4)
A2	1,006	5.9 (4.2-8.3)	6.0 (3.9-8.0)
B1	575	3.5 (2.0-5.9)	3.5 (1.6-5.4)
B2	241	n.a.	n.a.
B3	45	n.a.	n.a.
C	14	n.a.	n.a.
Body Mass Index (kg/m²)
Underweight (≤18,5)	16	n.a.	n.a.
Normal weight (>18,5-25)	873	5.8 (4.0-8.6)	6.0 (3.6-8.3)
Overweight (>25-30)	1,393	4.5 (3.4-6.1)	4.6 (3.2-6.0)
Obesity (>30-40)	1,128	7.8 (5.7-10.8)	8.0 (5.4-10.6)
Morbid obesity (>40)	108	n.a.	n.a.
Smoking
No	3,099	5.3 (4.3-6.6)	5.4 (4.2-6.5)
Yes	429	7.9 (5.1-12.2)	8.2 (4.6-11.9)

Please note: n.a. if <50 cases were at risk; CI: confidence interval.

This website is only accessable on large screens